Testing treatment for active cardiac sarcoidosis heart rhythm and function
Treatments studied
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This trial studies a treatment approach for people with active cardiac sarcoidosis, confirmed by specific heart rhythm/heart function problems and a PET scan. It may help by targeting the active inflammation driving heart conduction problems, rhythm events, or weak heart pumping.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cardiac sarcoidosis and at least one heart-related issue (serious heart block, slow heart rate, rhythm problems in the lower chambers, or weak left or right pumping).
- There is no other better explanation for your symptoms and heart findings.
- You had an FDG-PET scan within the last 6 months showing signs of active sarcoidosis, plus a heart perfusion scan.
- You also have lab or scan evidence supporting sarcoidosis (either a positive biopsy, or a chest CT showing lung sarcoidosis or enlarged chest lymph nodes).
- You can have a PET scan (not allergic/unsafe to PET; you’re able to tolerate the scan even if the machine is tight/claustrophobic).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with sarcoidosis that may or may not be affecting the heart. It uses special scans (PET and MRI) to look for heart involvement and track how the disease changes over time.
This study checks whether a special heart scan called PET/MRI can predict how sarcoidosis may affect your heart. It may help doctors better estimate heart risk and plan follow-up based on scan findings.
This study tests how doctors can best tell whether someone has cardiac sarcoidosis, a condition where inflammation affects the heart. It may help you get a more accurate diagnosis using expert guidelines and special heart tests, and it groups patients as proven, probable, or unlikely.
This trial tests if rilonacept can help people with cardiac sarcoidosis, a condition where inflammation affects the heart. You may join if you have active inflammation on a PET scan despite standard treatments.
This study collects and analyzes tissue or blood samples to better understand heart sarcoidosis and related inflammatory heart conditions. It may help doctors confirm diagnoses and improve care, especially in people with rhythm problems or results on heart scans.
This study tests if a special PET scan with 64Cu-DOTATATE can detect inflammation in the heart caused by sarcoidosis. It may help diagnose heart sarcoidosis more accurately in people with symptoms or known disease.
Hear when a new Cardiac Sarcoidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.